The European Medicines Agency has finalized a much-awaited guideline explaining how companies should use computerized systems and collect electronic data in clinical trials in accordance with existing legislation and good clinical practice requirements.
The provisions of the guideline – prepared by the EMA’s GCP Inspectors’ Working Group (GCP IWG) – will come into effect in six months. It replaces the EMA’s current “Reflection...